17-35422457-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018042.5(SLFN12):āc.572A>Gā(p.Asp191Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,202 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018042.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLFN12 | NM_018042.5 | c.572A>G | p.Asp191Gly | missense_variant | 2/4 | ENST00000304905.10 | |
SLFN12 | NM_001289009.2 | c.572A>G | p.Asp191Gly | missense_variant | 2/4 | ||
SLFN12 | XM_005257995.6 | c.572A>G | p.Asp191Gly | missense_variant | 3/5 | ||
SLFN12 | XM_024450822.2 | c.572A>G | p.Asp191Gly | missense_variant | 4/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLFN12 | ENST00000304905.10 | c.572A>G | p.Asp191Gly | missense_variant | 2/4 | 1 | NM_018042.5 | P1 | |
SLFN12 | ENST00000394562.5 | c.572A>G | p.Asp191Gly | missense_variant | 4/6 | 1 | P1 | ||
SLFN12 | ENST00000452764.3 | c.572A>G | p.Asp191Gly | missense_variant | 2/4 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 33
GnomAD4 exome Cov.: 35
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | The c.572A>G (p.D191G) alteration is located in exon 2 (coding exon 1) of the SLFN12 gene. This alteration results from a A to G substitution at nucleotide position 572, causing the aspartic acid (D) at amino acid position 191 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at